Engineered cell membranes help antibiotic carrying nanoparticles target drug resistant Gram negative bacteria, boosting ampicillin activity at far lower concentrations.
Gram-negative pathogens present a major clinical challenge owing to their dual-membrane envelope, which restricts drug uptake, and a versatile arsenal of resistance mechanisms including β-lactamase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results